These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34353327)

  • 1. Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization.
    Pignolo RJ; Hsiao EC; Baujat G; Lapidus D; Sherman A; Kaplan FS
    Orphanet J Rare Dis; 2021 Aug; 16(1):350. PubMed ID: 34353327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported baseline phenotypes from the International Fibrodysplasia Ossificans Progressiva (FOP) Association Global Registry.
    Pignolo RJ; Cheung K; Kile S; Fitzpatrick MA; De Cunto C; Al Mukaddam M; Hsiao EC; Baujat G; Delai P; Eekhoff EMW; Di Rocco M; Grunwald Z; Haga N; Keen R; Levi B; Morhart R; Scott C; Sherman A; Zhang K; Kaplan FS
    Bone; 2020 May; 134():115274. PubMed ID: 32062004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.
    Pignolo RJ; Baujat G; Brown MA; De Cunto C; Di Rocco M; Hsiao EC; Keen R; Al Mukaddam M; Sang KLQ; Wilson A; White B; Grogan DR; Kaplan FS
    Orphanet J Rare Dis; 2019 May; 14(1):98. PubMed ID: 31053156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases.
    Baujat G; Choquet R; Bouée S; Jeanbat V; Courouve L; Ruel A; Michot C; Le Quan Sang KH; Lapidus D; Messiaen C; Landais P; Cormier-Daire V
    Orphanet J Rare Dis; 2017 Jun; 12(1):123. PubMed ID: 28666455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most Fractures Treated Nonoperatively in Individuals With Fibrodysplasia Ossificans Progressiva Heal With a Paucity of Flareups, Heterotopic Ossification, and Loss of Mobility.
    Lindborg CM; Al Mukaddam M; Baujat G; Cho TJ; De Cunto CL; Delai PLR; Eekhoff EMW; Haga N; Hsiao EC; Morhart R; de Ruiter R; Scott C; Seemann P; Szczepanek M; Tabarkiewicz J; Pignolo RJ; Kaplan FS
    Clin Orthop Relat Res; 2023 Dec; 481(12):2447-2458. PubMed ID: 37156007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FOP Connection Registry: Design of an international patient-sponsored registry for Fibrodysplasia Ossificans Progressiva.
    Mantick N; Bachman E; Baujat G; Brown M; Collins O; De Cunto C; Delai P; Eekhoff M; Zum Felde R; Grogan DR; Haga N; Hsiao E; Kantanie S; Kaplan F; Keen R; Milosevic J; Morhart R; Pignolo R; Qian X; di Rocco M; Scott C; Sherman A; Wallace M; Williams N; Zhang K; Bogard B
    Bone; 2018 Apr; 109():285-290. PubMed ID: 28866367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteocalcin level is associated with the mortality in Chinese patients with Fibrodysplasia ossificans progressiva aged ≤18 years at diagnosis.
    She D; Li R; Fang P; Zong G; Xue Y; Zhang K
    BMC Musculoskelet Disord; 2020 Mar; 21(1):152. PubMed ID: 32143615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrodysplasia ossificans progressiva in China.
    She D; Zhang K
    Bone; 2018 Apr; 109():101-103. PubMed ID: 29175272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
    Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
    Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases.
    Kaplan FS; Zeitlin L; Dunn SP; Benor S; Hagin D; Al Mukaddam M; Pignolo RJ
    Bone; 2018 Apr; 109():281-284. PubMed ID: 29241828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with ACVR1
    Kou S; De Cunto C; Baujat G; Wentworth KL; Grogan DR; Brown MA; Di Rocco M; Keen R; Al Mukaddam M; le Quan Sang KH; Masharani U; Kaplan FS; Pignolo RJ; Hsiao EC
    Orphanet J Rare Dis; 2020 Jul; 15(1):193. PubMed ID: 32727600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of Senescent Cells From Injured Muscle Abrogates Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva.
    Wang H; Zhang Q; Kaplan FS; Pignolo RJ
    J Bone Miner Res; 2022 Jan; 37(1):95-107. PubMed ID: 34633114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective.
    Pignolo RJ; Bedford-Gay C; Cali A; Davis M; Delai PLR; Gonzales K; Hixson C; Kent A; Newport H; Robert M; Scott C; Kaplan FS
    Orphanet J Rare Dis; 2022 Apr; 17(1):168. PubMed ID: 35436894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report.
    Singh S; Kidane J; Wentworth KL; Motamedi D; Morshed S; Schober AE; Hsiao EC
    BMC Musculoskelet Disord; 2020 Apr; 21(1):204. PubMed ID: 32245464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrodysplasia ossificans progressiva: Review and research activities in Japan.
    Haga N; Nakashima Y; Kitoh H; Kamizono J; Katagiri T; Saijo H; Tsukamoto S; Shinoda Y; Sawada R; Nakahara Y
    Pediatr Int; 2020 Jan; 62(1):3-13. PubMed ID: 31774601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva.
    Kaplan FS; Zasloff MA; Kitterman JA; Shore EM; Hong CC; Rocke DM
    J Bone Joint Surg Am; 2010 Mar; 92(3):686-91. PubMed ID: 20194327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy in Fibrodysplasia Ossificans Progressiva: A Case Report and Systematic Review of the Literature.
    Botman E; Netelenbos JC; Rustemeyer T; Schoonmade LJ; Nieuwenhuijzen JA; Teunissen BP; Visser M; Raijmakers P; Lammertsma AA; Dahele M; Eekhoff M
    Front Endocrinol (Lausanne); 2020; 11():6. PubMed ID: 32117050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical-pathological correlations in three patients with fibrodysplasia ossificans progressiva.
    Wentworth KL; Bigay K; Chan TV; Ho JP; Morales BM; Connor J; Brooks E; Shahriar Salamat M; Sanchez HC; Wool G; Pignolo RJ; Kaplan FS; Hsiao EC
    Bone; 2018 Apr; 109():104-110. PubMed ID: 29033382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
    J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.